Leslie Z. Benet is Director at Impax Laboratories, LLC (IPXL). They have made 9 open-market trades across 1 company since 2010, most recently 2018-05-04.
CIK 0001003642
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $33K since 2011, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IPXL | 22,483 | $411K |
Shares reported on the most recent Form 4, priced at the 2017-05-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IPXL | SELL | 2016-08-15 | 2016-08-17 | $22.81 | $230K | +2.9% | +12.4% | -38.5% |
| IPXL | SELL | 2016-08-15 | 2016-08-17 | $22.81 | $230K | +2.9% | +12.4% | -38.5% |
| IPXL | SELL | 2015-08-31 | 2015-09-01 | $40.92 | $338K | -14.0% | +0.8% | +0.8% |
| IPXL | BUY | 2013-03-12 | 2013-03-14 | $16.72 | $8K | -14.0% | +0.8% | +0.8% |
| IPXL | SELL | 2012-08-14 | 2012-08-15 | $24.24 | $85K | -14.0% | +0.8% | +0.8% |
| IPXL | SELL · 10b5-1 | 2012-08-13 | 2012-08-13 | $23.96 | $31K | -14.0% | +0.8% | +0.8% |
| IPXL | BUY | 2011-08-08 | 2011-08-08 | $15.71 | $8K | -14.0% | +0.8% | +0.8% |
| IPXL | BUY | 2011-08-05 | 2011-08-05 | $17.25 | $17K | -14.0% | +0.8% | +0.8% |
| IPXL | SELL | 2010-12-01 | 2010-12-03 | $18.10 | $181K | -14.0% | +0.8% | +0.8% |
| IPXL | SELL | 2010-05-07 | 2010-05-10 | $17.10 | $205K | -14.0% | +0.8% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.